Stay updated on Belimumab in Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Belimumab in Lupus Nephritis Clinical Trial page.

Latest updates to the Belimumab in Lupus Nephritis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record presents details of the completed Phase 3 belimumab study for active lupus nephritis, including its design, eligibility criteria, locations, outcome measures, publications, and data-sharing information.SummaryDifference100%

- Check17 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2 while the page remains a 403 error screen.SummaryDifference0.2%

- Check38 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the previously accessible trial information and related resources on the page.SummaryDifference18%

Stay in the know with updates to Belimumab in Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belimumab in Lupus Nephritis Clinical Trial page.